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Abstract: 
Management of coma after cardiac arrest has evolved over the last decade, allowing an 
increasing proportion of patients to survive. Prognostication is an integrant part of post-
resuscitation care; current recommendations suggest the use of a multimodal approach 
combining clinical examination with additional modalities, including electro-physiology, blood 
biomarkers and brain imaging, to optimise prognostic accuracy. Neurologists are increasingly 
confronted with raising expectations and the necessity to provide early predictions of long-term 
prognosis. Given this new scenario, a critical appraisal of how to optimally use these modalities, 
accounting for individual situations and availability of resources, is needed. The purpose of this 
manuscript is to provide a review of prognostic tools from a neurological standpoint, to 
summarise their value and potential clinical utility with attention to poor and good prognosis, 
and to suggest a stepwise multimodal algorithm, with specific attention to appropriate timings 
and optimal combination of available prognosticators.  
 
 
 
We searched PubMed from Jan 2009, to January 2016, with the search terms “cardiac arrest”, 
“hypoxic-ischemic encephalopathy”, “prognosis”, “outcome”, “prognostication”, “clinical 
examination”, “myoclonus”, “status myoclonus”, brainstem reflexes”, “pupillary”, 
“pupillometry”, “motor reaction”, “pain”, EEG”, “reactivity”, “background”, “epileptiform” 
“status epilepticus”, “seizure”, “SSEP”, “N20”, “N70” “MMN”, “NSE”, “S100-b”, “brain CT”, 
“Brain MRI”, “diffusion”. We further searched bibliographies of relevant articles. We reviewed 
only clinical studies, randomised trials, and reviews published in English. The final reference list 
was generated on the basis of relevance to the scope of this Review. 
 
 
Glossary: CA=cardiac arrest, CI=confidence interval, CT=computer tomography, 
EEG=electroencephalography, FPR=false positive rate, MRI=magnetic resonance imaging, N20 =the first 
cortical somatosensory evoked potential, TTM =targeted temperature management. 
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Case 1 
A 60 year-old comatose woman is admitted after a cardiac arrest of respiratory cause. The first 
rhythm was asystole and the estimated total time from cardiac arrest to return of spontaneous 
circulation was 22 minutes. She undergoes targeted temperature management at 36° for 24 hrs. 
At day 2 after cardiac arrest, off sedation, clinical examination displays absence of motor 
response and all brainstem reflexes. The EEG is characterised by a monotonous alpha activity 
predominant in the anterior regions, and a non-reactive background to painful stimulation 
(Figure 1). Somatosensory evoked potentials (N20) are bilaterally preserved. At day 3, the 
second EEG shows a diffuse, slow and non-reactive background. Clinical examination differs 
from the previous day only for recovery of spontaneous breathing and presence of a right corneal 
reflex.  
(see Page XX, section: When and what to use, and how to put it all together - Intensive car 
withdrawal) 
 
Case 2 
A 70 year-old woman is admitted in coma following a cardiac arrest due to ventricular 
fibrillation. The estimated total time from cardiac arrest to return of spontaneous circulation is 18 
minutes. A myocardial infarction is diagnosed, and a primary angioplasty of occluded proximal 
right coronary artery is successfully realised. The patient is admitted to the intensive care unit, 
where sedation-analgesia and targeted temperature management to 33°C is maintained for 24 
hours. EEG during hypothermia is reactive and nearly continuous. Upon awakening, she shows a 
return of brainstem reflexes, no reaction to pain, and bilaterally preserved early cortical 
somatosensory evoked potentials. A second EEG shows diffuse, continuous slowing, preserved 
reactivity and no epileptiform components. Serum neuron-specific enolase peaks at 40 µg/L. 
Seven days after admission, the patient is still in coma. Brain diffusion MRI shows hyper-
intensities predominant in posterior cortical regions and hippocampi (see Figure 4, white 
arrows). The EEG is unchanged.  
(see Page XX, section: When and what to use, and how to put it all together – How to deal with 
uncertainty) 
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Introduction  
 
Cardiac arrest (CA) represents a major health problem1 with a yearly incidence of approximately 
50 to 110 per 100’000 persons worldwide.2 Progress in advanced life support, access to emergent 
coronary angiography, implementation of targeted temperature management (TTM, with induced 
mild hypothermia to 33°C or strict normothermia at 36°C for 24 hours 3), of post-resuscitation 
care targeting optimal support of cerebral and organ perfusion, and prevention of extra-cerebral 
systemic insults (hyperglycemia and infections), resulted over the last decade in an overall 
increase of CA survival,4,5 and of chances to be discharged with good neurological recovery 3,6 
and quality of life .7-9 
In line with this evolution, CA has become a leading aetiology of coma and a frequent cause of 
admission to the intensive care unit. Clinicians involved in the care of comatose CA adults are 
confronted with increasingly optimistic expectations, and in the early phase of ICU management 
neurologists are regularly requested to provide predictions of long-term outcome. Post-CA brain 
dysfunction, predominantly resulting from global ischemia-reperfusion injury, is the principal 
determinant of prognosis. Additional factors may further alter brain function, mainly sedatives 
used to maintain TTM and post-CA organ dysfunction; these aspects might substantially delay 
recovery of cerebral function for up to 5-6 days 10, leaving caregivers and families with an 
unacceptably long delay of uncertainty. In this setting, despite neurological examination being 
the first and most important step for the evaluation of patients,11 a growing body of clinical 
evidence demonstrates that the integration of additional modalities, including electro-
physiological investigations, blood biomarkers of cerebral injury, and brain imaging, improves 
the accuracy of early (24-72 hours) coma prognostication.  
Neurologic consultation and multimodal prognostic assessment has nowadays become an 
integrant part of post-resuscitation care. In practice, a complete battery of tests is either not 
always necessary according to the clinical situation, or not available in every facility; while 
university centers may dispose on almost unlimited resources, peripheral hospitals have to rely 
on fewer tools. While several excellent reviews and guidelines on this topic have been recently 
edited, most are addressed to intensivists or resuscitation specialists and essentially focus on 
prognosticators of poor outcome. 12-15 We here critically review recent literature in this evolving 
field and provide the value of each prognostic tool, highlighting false-positive rates (FPR) and 
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positive predictive values (point estimates and 95% confidence intervals, retrieved from original 
publications, meta-analyses, or calculated using binomial distributions) not only for poor, but 
also for favourable prognosis. Outcome was defined by cerebral performance categories (CPC, 
categorized as good: CPC 1 [back to baseline], or 2 [moderate impairment]; versus poor: CPC 3 
[severe impairment], 4 [vegetative or comatose], 5 [dead])16. Of note, however, CPC 3 represents 
a heterogeneous condition: depending on the time of assessment and the possible further 
evolution of the patient, it may be related with a more favourable outcome. We also 
acknowledge the limited evidence supporting the use of each prognosticator, and the inevitable 
limitation imposed by the possibility of the so-called “self-fulfilling prophecy” (i.e. if a variable 
is a priori believed to be indicative of poor prognosis, leading to withdrawal of life-sustaining 
therapies, it will ultimately determine the outcome). 17,18  
Our purpose is to provide a general neurology audience with an updated, critical review of 
available prognostic tools for coma prognostication after CA in adults, to summarise their 
respective value and potential clinical utility, and to suggest a stepwise multimodal algorithm, 
paying specific attention to appropriate timings and combination of prognosticators. Finally, an 
outlook on promising emerging modalities will be offered.  
 
Clinical examination  
Neurological examination is essential for prognostication, as it directly reflects brain function. 
Evaluation of brainstem reflexes, motor responses to pain, and myoclonus during the first 72 
hours after arrest represented the standard evaluation before the advent of TTM 19 and retains its 
prognostic value in patients treated with TTM (at target temperatures of 32 to 36°C).20 However, 
these features can be altered by TTM and residual sedation, therefore repeated assessments are 
often necessary. Clinical improvement can be heralded by appearance of eye tracking or 
movements to command. It is important to recognize that predictive performances of clinical 
examination may be limited by the fact that these responses were systematically used for clinical 
decisions in the studied cohorts, raising concerns regarding at least some degree of self-fulfilling 
prophecy.  
Pupillary light and corneal reflexes  
6 
 
Bilateral absence of pupillary light reflexes at 72 hours is a robust indicator of poor prognosis, 
whether the patient is treated with TTM (FPR 0.5%, 95% CI: 0-2%)12,13,17,20,21 or not (FPR 0.5%, 
95% CI: 0-8%).13,19,20 While absence of pupillary responses within 24 hours is not incompatible 
with good recovery, particularly in hypothermic patients (FPR 8%, 95% CI: 1-25%13), their 
presence at 72 hours poorly identifies patients who will awake (predictive value: 61%, 95% CI: 
50-71%20). Lack of corneal reflexes at 72 hours also strongly correlates with poor prognosis, 
although with lower accuracy than pupillary reflexes, especially among patients who received 
sedatives or neuromuscular blockade (FPR 5%, 95% CI: 0-25%13,17); again, their presence is an 
unreliable predictor of good outcome (predictive value: 62%, 95% CI: 51-72%20).  
Motor response 
Absent or extensor response to pain at 72 hours was considered a reliable indicator of poor 
outcome before the broad utilization of TTM.19 However, this is the physical sign most 
influenced by sedatives, opiates, and neuromuscular blockade; consequently, motor responses 
are less reliable in patients undergoing TTM (FPRs up to 10-24%, 95% CI: 6-48%).17,18,22 
Evaluation requires strong stimulation and the exclusion of residual effects of pharmacological 
sedation, which can be prolonged by TTM and/or reduced pharmacologic clearance (e.g., 
hypothermia, renal or liver dysfunction). 10 Timing and proficiency of the examination can 
greatly impact the elicited response and therefore its prognostic accuracy. Also, when assessing 
motor signs it is important to remember that while an extensor or absent response does not 
necessarily mean that the patient will not awaken, a flexor or even a localizing movement does 
not always signify that she will recover (positive predictive value 81%; 95% 66-91%).18  
Myoclonus  
Myoclonus has long been known to predict poor outcome after CA, 19,23 but recent reports of 
patients who achieved good prognosis despite early post-anoxic myoclonus 24-27 raised questions 
about its prognostic accuracy. Indeed, up to 9% of patients with myoclonus may survive.25,28 Its 
precise characterization is crucial: not all “twitches” have the same prognostic implication, 
depending on semiology, duration and associated EEG findings. Generalized status myoclonus 
(multifocal spontaneous twitches lasting more than 30 minutes, occurring even under TTM and 
sedation) is commonly accompanied by malignant, unreactive EEG patterns (see next section) 
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and consistently associated with poor outcome (FPR 0%, 95% CI: 0-3%20). Conversely, brief 
myoclonic jerks restricted to the face or trunk, controllable with sedatives, along with a more 
benign (i.e.: continuous and reactive) EEG, do not portend an invariably poor outcome (FPR up 
to 5-11%, 95% CI: 3-26% 13 22).  These considerations may explain the markedly different FPR 
across studies and highlight the importance of careful clinical assessments and interpretation in 
the context of other prognosticators, especially EEG. Only this multimodal approach may 
prevent interrupting care too early in patients who still have chances of awakening.    
 
Electroencephalography (EEG)  
Its signal is generated by cortical post-synaptic potentials; this is a broadly available, non-
invasive, relatively cheap real-time investigation of electrical brain activity, which has been 
routinely used for decades in this setting.29 The recent regain in interest on EEG paralleled the 
important progresses in post-CA care and outcome. Prognostication has taken a renewed place, 
and in this context EEG is of great help, also considering that its features correlate with the 
degree of neuronal injury.30 Availability of automated algorithms for its screening,31 and of CT 
and MRI compatible electrodes,32 have facilitated its use in critical care patients. Technical 
expertise is pre-requisite for correct interpretation.33 The American Clinical Neurophysiology 
Society recently edited standardized guidelines for interpretation,34 which have been validated in 
this setting,35 and are strongly recommended to allow comparisons among different settings. 
While studies on quantitative analysis or reactivity did not use these features to decide 
withdrawing life-sustaining measures, background and epileptiform features may be affected by 
a self-fulfilling prophecy.  
Mild hypothermia does not exert major effects on EEG interpretation, 36 whereas sedative agents 
used during TTM can have an impact depending on doses. Several recent studies suggest, 
however, that despite sedative infusions in the range of 0.1-0.2 mg/kg/hrs (midazolam) or 2-3 
mg/kg/hrs (propofol), prognostic accuracy of EEG is better during the first 24 hrs (and TTM) 
than after 2-3 days;37-39 of course, if sedation is much more important, EEG assessments 
(especially background and reactivity) may be influenced. EEG findings may be categorized into 
three main aspects:  
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Background activity 
This represents the first parameter to be interpreted, and is readily informative of global cerebral 
functioning. Worsening of brain dysfunction goes alongside with increasing background slowing 
and decreasing amplitude. Several groups focused on the role of a low voltage (<20 µV) or 
isoelectric (suppressed) background at 24 hrs (FPR 0%, 95% CI: 0-17% 39,40), of burst-
suppression at any time (FPR 0%, 95% CI: 0-11%39), of burst-suppression with identical bursts 
(FPR 0%, 95% CI: 0-17%41), and of spontaneously discontinuous background during TTM (FPR 
7%, 95% CI: 0-24% 30) predicting unfavourable outcome. Conversely, a continuous background 
as soon as 12 hours after CA has been correlated with a high likelihood of awakening (positive 
predictive value 92%, 95% CI: 80-98% 37); a normal voltage background at 24 hrs has a similar 
meaning (72%, 95% CI: 55-88% 39). An exception is the so-called alpha-coma, an anterior 
prominent rhythm without reactivity that is associated with poor prognosis (9 out of 9 patients 
reported with poor outcome 42) (Figure 1).  
Background reactivity 
Reactivity is elicited by auditory or noxious stimulations and is characterised by either transitory 
attenuation or increase of electrical activity (Figure 2). Lack of reactivity has been shown to 
correlate with poor outcome if assessed after TTM (FPR 7%, 95% CI:  1-15% 18,43), even more 
robustly during TTM (FPR 2%, 95% CI:  0-9% 38,44). Conversely, reproducible reactivity may 
indicate subsequent awakening, during TTM (positive predictive value 86%, 95% CI: 77-92%45), 
and thereafter (78%, 95% CI: 64-88%18). Finally, so-called “stimulus-induced rhythmic, periodic 
or ictal discharges” (SIRPIDs), not representing a physiological reactivity, occur in about 15% of 
patients and herald a poor prognosis (FPR 2%, 95% CI: 0-11%), particularly if observed during 
TTM and sedation.46 An important limitation of EEG reactivity relies in the potential lack of 
generalization, mainly due to subjective assessment, variable inter-rater agreements;35,47 a 
standardized stimulation protocol may improve this aspect.48  
Epileptiform features 
Sharp waves, (poly-) spikes, spike and waves are only exceptionally observed in isolation, as 
they very often present as repetitive (periodic or rhythmic) patterns. Occurrence of such features 
after TTM is related to poor outcome (FPR 9%, 95% CI: 2-21% 18); this seems even more true if 
epileptiform discharges are observed during TTM, under sedation with antiepileptic properties 
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(FPR 0%, 95% CI: 0-30%30,49). Nevertheless, a subset of patients with electrographic status 
epilepticus appearing only after TTM and sedation weaning, especially those who have 
preserved brainstem reflexes, background reactivity and somatosensory evoked potentials, may 
have a chance of reaching reasonable functional outcomes.50 Quantitative analysis suggests that 
subjects with epileptiform features reaching good outcome show higher background continuity, 
higher discharge frequency, but lower discharge periodicity.51 We believe that these patients 
should be treated aggressively with anticonvulsants and, if needed, pharmacological coma. 
Treatment duration in this context is not known, but it does not seem reasonable to extend 
therapy beyond two weeks if the patient does not awaken.  
Standard versus continuous EEG 
Some groups advocate the use of continuous EEG for up to 48 hrs;37,39 yet, two standard EEG 
recordings (20-30 minutes) including stimulations for reactivity performed within 48 hours of 
CA have been reported to offer comparable information to continuous EEG, 52 at lower costs.53 
Apart from the particular case of EEG monitoring of post-anoxic status epilepticus, intermittent 
EEG represents a valid alternative for centres with limited resources. Since electrical activity 
may evolve over time,40,54-56 repeated assessments are advisable, in particular over the first 48 hrs 
following CA. Reduced montages with as few as two channels have been described, including 
amplitude-integrated analysis and bispectral index;54-57 they may represent an alternative for 
assessing background and reactivity, however they are less sensitive for detection of epileptiform 
transients and epileptic seizures. Recordings performed too early may overestimate the degree of 
brain injury, and, on the other hand, very precocious epileptiform features seem rare (these most 
commonly appear after 12-24 hours58): for these reasons, depending on local availability, EEG 
assessments can be started at 12 hours after CA.52 Earlier studies may detect some very early 
seizures, but should not be used for judging on background activity and reactivity. 
 
Somatosensory evoked potentials  
Early latency evoked potentials  
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These signals result from the averaging of cortical electrographic responses generated after 
repetitive electrical stimulations of the median nerve through afferent pathways to the 
contralateral postcentral gyrus, where a negative deflection appears about 20 ms after the 
stimulation (and is thus called N20) (Figure 3). While they are less widely available than EEG, 
particularly in peripheral hospitals, they have been extensively studied for prognostication after 
CA. Bilateral absence of the N20 response is robustly correlated with a poor outcome, mostly 
after TTM (FPR 0.5%, 95% CI: 0-2%10,17,37,38,59), but also during TTM (FPR 0%, 95% CI: 0-2% 
13,59). While the evoked potentials accuracy is extremely high for prediction of poor prognosis 
(notwithstanding a certain degree of self-fulfilling prophecy), their value to predict favourable 
outcome is disappointing, as positive predictive values of bilaterally present N20 oscillate from 
40% (29-50%)37 to 58% (95% CI: 49-68%)38, clearly lower than a continuous, reactive EEG 
background (>80%).45 Furthermore, evoked potentials have a lower sensitivity to detect patients 
who will die (43%; 95% CI: 31-57%) compared to absent EEG reactivity during TTM (74%; 
95% CI: 62-84%);38 of note that study did not include EEG reactivity for decision of supporting 
measures withdrawal. In line with this, evoked potentials do not provide additional information 
when EEG, clinical evaluation and biomarkers are also available, 37,38 reflecting the fact that 
while electroencephalographic waves are generated by cortico-cortical interplays, early-latency 
evoked potentials only represent averaged signals limited to an afferent pathway.60 It has recently 
been suggested that quantitative assessment of the N20 amplitude offers additional prognostic 
information,61 but this observation need to be replicated in different cohorts. 
Middle latency evoked potentials  
These are elicited by intra-cortical associative interactions, and may be recorded up to 100 ms 
following stimulation. While they should better reflect functional connectivity and thus allow 
prognostication of awakening, they are used far less commonly than early-latency potentials, due 
to technical recording issues. A study before the TTM era reported a PPV for awakening as high 
as 97% if middle-latency responses were present; 62  however, this was challenged by another 
study reporting that only 28% of those with middle-latency responses reached a good outcome. 63 
A recent study suggests that the painful modality may be informative of consciousness recovery (PPV 
100%, 95% CI 87-100%) even before EEG reactivity.64 
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Biochemical markers  
Monitoring biomarkers of neuronal injury is a field of intense clinical investigation; an extensive 
summary is beyond the scope of this review, and the reader is referred to a recent document.65 
Although a wide variety of proteins have been identified, only neuron-specific enolase (a marker 
of neuronal damage) and S-100 beta (reflecting astrocyte damage) have been extensively studied 
by independent groups; this section thus concentrates on these two proteins, while other are 
presented in the “Promising newer prognostic tools” section. Studies on biomarkers can be 
affected at least in part by a self-fulfilling prophecy.  
Neuron-specific enolase  
This enzyme is released by dying neurons, and so far has been the most studied biomarker for 
CA prognosis. Elevated NSE levels correlate with the extent of neuronal injury and EEG 
alteration.30 A prospective study before the advent of TTM found that a serum NSE > 33 µg/L 
between 24 and 72 hours after CA was uniformly associated with poor outcome (FPR 0%, 95% 
CI: 0-3%66). However, results were more variable in retrospective series without TTM (FPR 9%, 
95% CI: 1-29% for the cut-off of 33 µg/L20; maximal levels in patients with good outcome 
ranging from 48 µg/L at 24 hrs to 80 µg/L at 72 hrs).13,67  
The prognostic reliability of neuron-specific enolase has been further questioned by studies 
conducted in subjects treated with TTM at 33°C, where an unacceptably high FPR of up to 29% 
(95% CI: 11-33%) for a threshold of 33 µg/L was repeatedly shown.10,17,20,30,68,69 It is nowadays 
not recommended to apply one particular threshold, 13,28 and the limit should be in any case 
higher than previously considered 70. Whether there is a threshold beyond which good recovery 
is no longer possible is indeed matter of debate: while it is uncommon for to experience 
favourable recovery at NSE > 60-80 µg/L within the first 72 hours,70,71 exceptional cases despite 
very high values (up to 151 µg/L) have been reported.69,72 In a recent large multicenter study, 
cut-offs as high as 120 µg/L at 48 hrs and 50 µg/L at 72hrs were necessary to keep FPRs at 0-
1%. 68 Trends on serial measurements over the first 72 hours could be more useful than a single 
value,68 but the best way to interpret the results remains to be elucidated. Furthermore, levels <33 
µg/L are inconsistently related to good outcome (positive predictive value 63%, 95% CI: 52-73% 
38).  
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An important caveat is sample handling and laboratory expertise. Variability in serum levels can 
be seen across laboratories or following different assessment methods;73 spurious results can be 
observed when samples are haemolysed (e.g., during hypothermia).74 Levels could also 
theoretically increase because of haemolysis in patients undergoing extra-corporeal membrane 
oxygenation; the extent of this phenomenon deserves further investigation, but in the meantime it 
is advisable to be cautious in this setting. Since neuron-specific enolase is also present in 
neuroectodermal cells, high levels can be encountered in patients with small cell lung carcinoma. 
Serum S-100 beta protein  
This protein is released by glial cells after brain insults, and also has extra-cerebral sources, such 
as adipose tissue and muscle. Levels are measured far less commonly than neuron-specific 
enolase, probably because of test availability (neuron-specific enolase serves also as a tumour 
marker), and thresholds for uniform identification of poor outcome have also been very variable 
across studies, regardless of whether TTM was used13. Given its shorter biological half-life, 
serum S-100 beta protein raises earlier, and high levels (>0.5 µg/L) could signal poor prognosis 
even within the first 24 hours.75,76 Yet, since early prognostication using a single parameter 
should be discouraged, the practical value of this difference in kinetics is questionable. 
 
Neuroimaging  
Brain imaging can help revealing structural alterations and quantifying the extent of post-anoxic 
damage, and its application for coma prognostication is relatively new. Most studies are 
retrospective and many evaluated imaging as a single tool. Neuroimaging is currently used less 
frequently than clinical and neurophysiological examinations. Studies where clinicians were not 
blinded to imaging findings may have introduced some degree of self-fulfilling prophecy.  
However, when this was not the case a good correlation between extensive cortical injury on 
magnetic resonance imaging and poor outcome was found. 77,78 
Brain computed tomography (CT)  
CT provides valuable information when the CA aetiology is uncertain and an intracranial 
haemorrhage should be ruled out. However, intracerebral causes of CA are very infrequent 
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(particularly following ventricular fibrillation) and the benefit of a routine brain CT on admission 
must be balanced with the potential delay in starting TTM and post-resuscitation care.79 CT signs 
of brain hypoxia include loss or reduced gray-white matter discrimination and sulcal edema or 
effacement. Loss of gray-white matter discrimination within 2 hours after asphyxia seems a 
reliable predictor of poor prognosis (FPR 0%, 95% CI: 0-12%); the interobserver concordance 
was good, but identification of survivors was poor (positive predicted value 37%, 95% CI: 9-
75%).80 A multicenter study on patients undergoing hypothermia after CA found that although 
reduced gray-white matter ratios predicted poor outcome with FPR 0%, sensitivity (3.5-6%) was 
extremely low; furthermore, including CT findings into a multivariable model with other 
prognosticators did not improve prediction.81 Another recent study came to similar conclusions 
(FPR 0%, 95% CI 0-4%; sensitivity 14-20%, moderate-to-good interrater agreement).77 
Brain magnetic resonance imaging (MRI) 
MRI has higher resolution than CT and can better identify structural abnormalities in the 
neocortex, deep grey nuclei, and hippocampi. Although the superiority of MRI on CT for 
outcome prediction has not been formally demonstrated, many recent investigations focused on 
MRI (particularly, diffusion-weighted MRI). In poor outcome patients, occipital and mid-
temporal cortex and the putamen may exhibit restricted diffusion (bright signal on diffusion-
weighted imaging, with corresponding dark signal on apparent diffusion coefficient maps) 
indicative of cytotoxic edema.78 Quantitative assessments across different areas have been 
reported to have an FPR 0% (95% CI: 0-22%) for poor outcome in studies with excellent 
interrater agreement, 82,83. A retrospective multicenter assessment using the same quantitative 
threshold also reported a slightly lower performance (FPR of 9% ; 95% CI: 2-25%)84, similar to 
an FPR of 7% (95% CI: 2-18%) in a large retrospective multicenter study from Korea.85 
However, diffusion-weighted MRI did not perform as well in another recent study, where a very 
high FPR (54%; 95% CI: 26-80%) was reported 86 (Figure 4). Furthermore, lack of diffusion 
changes does not consistently predict a good outcome (positive predictive values: 73%, 95% CI: 
45-92% 82; or 75%, 95% CI: 63-85% 85). It is recommended to perform MRI between 24-48 
hours and 7 days after CA.87  
Given the current relatively low level of evidence,88 diffuse structural signs of post-anoxic injury 
on either brain CT or MRI seem less robust predictors than brainstem reflexes and 
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electrophysiological findings.13 Difficulties inherent to transporting critically ill patients to the 
scanner and the still unclear prognostic value of imaging techniques (especially when evaluated 
only qualitatively) explain why they remain optional in most prognostication algorithms.13,15,89,90  
In practice, we recommend brain CT for disclosing a cerebral etiology when an evident CA 
cause is lacking. Brain MRI may be considered in centres with high-volume and expertise to 
complement multimodal assessments in patients who, despite lacking unfavourable prognostic 
signs on clinical, electrophysiological, and blood tests, are in persistent coma after several days.  
 
When and what to use, and how to put it all together 
The optimal prognostic tool  
Clinical examination is obviously mandatory in every patient, and electrophysiology is strongly 
recommended: even if pupillary light reflexes are lacking at 72 hours, we believe that one among 
EEG or evoked potentials is necessary to confirm prognostication of poor recovery. The EEG 
advantages are higher accuracy in early prediction of good recovery and sensitivity for poor 
prognosis, and seizures identification. Additional investigations may corroborate these 
evaluations, according to local practices and expertise. Available prognostic tools are 
summarized in Tables 1 and 2; the vast majority is oriented towards poor prognosis. 
The optimal timing 
While EEG performed at 12-24 hours after CA seems to be already very informative of 
prognosis, since TTM now represents the current standard of care, multimodal assessment 
including clinical examination and electro-physiologic studies (normothermic EEG and/or 
evoked potentials) has to be carried out after return to normothermia and discontinuation of 
sedation for a sufficient time. The earliest time window is after 48 hours; it is nevertheless 
mandatory to repeat clinical examination at 72 hours in those who do not show clear signs of 
awakening. 13,15 These early tests orient prognostication in the majority of patients: those already 
starting to awaken, or having convergent signs of irreversible brain injury (absent pupillary and 
corneal reflexes, EEG with burst-suppression background and no reactivity, absent cortical 
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evoked potentials) do not need additional tests. Biochemical markers or imaging are 
confirmatory tests for poor prognosis, but not mandatory in each case. 
How to deal with uncertainty 
Multimodal assessment is supported by a growing body of evidence and is strongly advocated 
whenever a doubt persists, since each single tool, when used alone, carries risks of false 
prediction. 13,15,37,38 Recent work has focused on the optimal combination of prognostic 
parameters: EEG background reactivity and/or continuity, clinical evaluation (particularly 
myoclonus and brainstem reflexes), and neuron-specific enolase seem to have the best predictive 
value to identify poor outcome patients. 37-39 Unfortunately, to date, no combination of tests 
heralding good prognosis can be supported by evidence.  
We propose a stepwise approach, summarized in Figure 5. If, following the aforementioned 
investigations, the patient still remains comatose despite the lack of poor outcome predictors, 
intensive care should be continued while the two core prognostic tools (clinical examination and 
EEG) are periodically reassessed over the subsequent days. At that point, blood biomarkers 
should be available, but repeating them and evoked potentials beyond 72 hours does not appear 
to bring any additional useful information. Brain MRI may prove useful, as it can reveal 
alterations reflecting cerebral damage, whose significance needs to be interpreted according to 
the clinical context. Case 2 is an illustrative example, where all prognostic tools were used: 
despite MRI alterations potentially portending poor prognosis, there was no other robust sign of 
poor outcome. In particular, the presence of repeated continuous, reactive EEG motivated to 
pursue intensive care, and the patient awoke shortly thereafter; at three months her CPC was 2. 
 
Intensive care withdrawal  
To minimise the risks of false pessimistic predictions, interruption of life-sustaining measures 
should be considered only in the presence of at least two tools with very low FPR for poor 
outcome (i.e., clinical examination plus electrophysiology), without any discordant information 
between tests (e.g., clinical signs of recovery of awareness, such as eye tracking or following 
orders, or a continuous, reactive EEG). While FPR point estimates of the aforementioned tools 
are all below 2%, confidence intervals for EEG are relatively wide; this reinforces the need of a 
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multimodal approach. Case 1 illustrates how clinical examination and EEG after 48 hours from 
CA orient towards a poor prognosis with high accuracy, even with preserved evoked potentials. 
Indeed, intensive care was withdrawn and the patient died shortly thereafter. 
 
Decision about withdrawal of life-sustaining measures is an essential, although potentially 
challenging, part of care. This should be reached through interdisciplinary consensus (at a 
minimum including the intensivist and the neurologist/neurophysiologist) and with close 
involvement of the patient’s family, considering the patient’s known or written directives, if 
available, as well as her biological and psychosocial backgrounds. The use of an algorithm must 
always be tailored to each individual situation. It is to underscore that when supportive care is 
continued in patients without overt interaction for several weeks or months, only a subset might 
show improvement of awareness beyond one year, but virtually all of them will remain in a 
severe, dependent state and have poor quality of life 91. In the relatively few instances where 
prognosis cannot be determined, we conduct detailed family discussions during the first two-
three weeks, so to clarify what would be the maximal acceptable and tolerated degree of 
functional impairment, and provide commensurate care based on individual preferences and 
values, in order to avoid futile treatment resulting in a severe handicapped survival.  
 
Promising novel prognostic tools   
The need of identifying additional prognosticators derives from two considerations: potential 
usefulness of quantitative assessments, and need for robust tools not only for poor, but also for 
good outcome. Given their exploratory nature, studies on these parameters are less hampered by 
the self-fulfilling prophecy, as they are still not used for prognostication in practice. The most 
important barriers to wider applicability of these techniques are the uncertain generalisability 
(i.e.: most tools were investigated by just one or a few groups), and limited availability (this 
seems especially true for biomarkers and long-latency evoked potentials).   
Automated pupillometry 
Automated devices to quantify pupillary responses to light stimuli are available on the market; 
preliminary studies suggest that quantitative infrared automated pupillometry may be superior to 
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standard qualitative examination.92 Until validation, correlation with direct visual examination 
remains necessary.93 
Long-latency evoked potentials 
These represent higher-order cortical reaction occurring more than 100ms after stimulation of the primary 
sensory areas. The response to deviant auditory stimuli in a sequence of standard stimuli, called mismatch 
negativity, was described after several days or weeks following CA in the pre-TTM era, and its presence 
is highly predictive of awakening.94 Recently, this approach has been refined by means of automated 
voltage topography analysis of records performed during acute coma: the vast majority of patients 
showing a progression of auditory discrimination between the first and the second assessment within 
the first 48 hrs had a good recovery.95 This novel paradigm may identify very early patients with 
favorable prognosis.96  
Other biomarkers 
Several proteins have been proposed, such as plasma neurofilament heavy chain,97 serum glial 
fibrillary acidic protein,98 brain derived neurotrophic factor, and tau protein,99 but sample sizes 
are limited: further data are needed before these biomarkers can be routinely used. Elevated 
levels of systemic proteins, such as serum procalcitonin, are found in the first 48 hours following 
global ischemia-reperfusion injury, and have been associated with increased mortality.100 
Cerebral oxygenation 
Low cerebral oxygenation levels, a marker of poor prognosis,101 can be assessed invasively, but 
this is not practical in CA patients. It can also be estimated non-invasively by means of near-
infrared spectroscopy and the measurement of regional cerebral oxygen saturation.102 This 
approach was tested in an extra-hospital setting to predict likelihood of resuscitation after CA.103 
A recent meta-analysis including 9 studies and 315 patients found that higher initial and average 
cerebral oxygenation are associated with greater chances of return of spontaneous circulation,104 
but to date no robust data are available to predict in-hospital or long-term prognosis. 
 
Conclusion  
Prognostication after CA has become an integral part of post-resuscitation care. Neurological 
consultation is increasingly requested, and neurologists are confronted by caregivers and families 
with expectations for high accuracy in outcome prediction. Over the last decade, post-CA 
prognostication has evolved towards a multimodal approach relying on clinical examination and 
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judicious integration of the information provided by multiple tests. Prognostication should never 
be based on a single indicator: while some variables have a very low FPR for poor outcome, they 
do not occur in isolation (e.g. bilateral absence of cortical responses on somatosensory evoked 
potentials would not be expected in patients with localizing responses on physical examination 
or a reactive EEG background). Multimodality assessment provides reassurance about the 
reliability of a prognostic estimation by offering concordant evidence from different sources, 
which should all make sense together. This approach is supported by an abundant body of 
clinical evidence and is strongly recommended. 13-15,89,90 
Confounders, however, exist: sedative drugs undergoing delayed clearance with hypothermia and 
renal or liver injury must always be formally excluded. Self-fulfilling prophecy is an important 
issue, intrinsic to virtually all studies on prognostication after CA.17,18 We acknowledge that no 
major prognosticator has been tested in a strictly blinded manner, and that evidence level is 
globally low to very low. Notwithstanding these limitations, relying on an algorithm 
incorporating information from multiple modalities is at present the best way to maximize 
prognostic reliability. When this remains uncertain, additional time and utilization of the full set 
of modalities is clearly recommended. The stakes are too high to rush or take chances.    
While most available literature focuses primarily on indicators of poor prognosis, in this review 
we also highlight early predictors of good recovery, especially EEG background and reactivity. 
Estimating prognosis after CA is not only about delivering bad news; it is also, and hopefully 
more frequently so in the future, about identifying reliable signs of good prognosis that can be 
confidently shared with families; this can prove very rewarding and represents an important task 
of neurologists involved in the care of CA patients. An additional, stimulating challenge for the 
upcoming years will be to further refine our understanding of which factors can predict excellent 
cognitive recovery.  
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Table 1: Overview of prognosticators including their estimated false positive rates (1-specificity) 
in adult patients treated with targeted temperature.  
 
 
Feature related to good 
outcome 
Positive predictive 
value (95%CI) 
Feature related to poor outcome 
False positive 
rate (95%CI) 
Clinical 
examination 
Pupillary light 
reflex 
Bilaterally present >72hrs 61% (50-71%) Bilaterally absent >72h 0.5% (0-2%) 
Corneal reflex Bilaterally present >72hrs 62% (51-72%) Bilaterally absent >72h 5% (0-25%) 
Early 
myoclonus 
NA 
Present      <48 hrs with epileptiform EEG 
(status myoclonus) 
0% (0-3%) 
Present      <48 hrs with continuous, reactive 
EEG 
5-11% (3-26%) 
Motor reaction 
to pain 
Flexion or better >72 hrs 81% (66-91%) Absent or extension posturing >72h 
10-24% (6-
48%) 
EEG 
Background  
Continuous at 12-24 hrs 92% (80-98%) Diffuse suppression or low voltage at 24 hrs 0% (0-17%) 
Normal voltage at 24 hrs 72% (53-86%) Burst-suppression at 24 hrs 0% (0-11%) 
Reactivity to 
stimuli 
Present during hypothermia 86% (76-92%) Absent during hypothermia 2% (0-9%) 
Present after return of 
normothermia 
78% (64-88%) Absent after return of normothermia 7% (1-15%) 
SIRPIDs NA Present at any time 2% (0-11%) 
Repetitive 
epileptiform 
transients 
NA 
Present during hypothermia 0% (0-30%) 
Present after return of normothermia 9% (2-21%) 
SSEP 
Bilaterally present 58% (49-68%) 
Bilaterally absent after return of 
normothermia 
0.5% (0-2%) 
Serum NSE 
<33 µg/L at 48 hrs 63% (52-83%) 
> 120 µg/L at 48 hrs 
>68 µg/L at 48 hrs 
0% (0-1%) 
1% (1-3%) 
Brain CT  Normal gray-white matter at 
2-48 hrs  
37% (9-75%) Reduced gray-white matter ratio at 2-48 hrs  0% (0-12%)% 
Brain MRI Absence of reduced diffusion 
at 24hrs - 7days 
73% (45-92%) Reduced diffusion at 24hrs - 7days 
0% (0-22%), 
54% (26-80%)  
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CI=confidence intervals, CT=computed tomography, EEG= electroencephalography, MRI=magnetic resonance 
imaging, NSE= (serum) neuron-specific enolase, NT=normothermia, SIRPIDs= stimulus induced rhythmic, 
periodic, or ictal discharges, SSEP=somatosensory evoked potentials, TTM= targeted temperature management. 
Table 2: Overview of strenghts and weaknesses of main prognostic tools. 
Prognostic tool Strengths Weaknesses 
Clinical examination - Very low FPR for poor 
prognosis (especially 
pupillary light reflex) 
- Identify early signs of 
awareness  
- Motor response may have high FPR (up to 
25%) for poor prognosis 
- Reliability may be reduce by lingering 
sedation, organ failure, and hypothermia 
- Myoclonus not invariably correlating with 
death (needs to be integrated to EEG). 
Electroencephalography - Low FPR for poor prognosis 
(especially absence of 
continuous background and 
reactivity) 
- Good accuracy in predicting 
favorable prognosis 
(especially presence of 
background and reactivity) 
- Allows detection and 
management of seizures 
- Lack of standardization for stimulus 
application (reactivity) 
- Requires expert interpretation. 
Early somatosensory 
evoked potentials 
- Very low FPR for poor 
prognosis 
- Low accuracy in predicting favorable 
prognosis 
- Lower sensitivity than EEG for predicting 
poor prognosis  
- Requires expert interpretation 
- Not available everywhere 
Biomarkers - Additional tool to confirm 
poor prognosis 
- Not reliable to identify favorable prognosis 
- Requires experienced laboratory and expert 
interpretation 
Brain imaging - Additional tool to confirm 
poor prognosis 
- Not reliable to identify favorable prognosis 
- Requires high-volume centers and expert 
interpretation 
FPR: false positive rate 
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Figure legends 
1: Alpha coma, a frontally predominant alpha rhythm in a comatose patient, nonreactive to 
painful stimulation (marker in the middle on the top) in a 70 year-old woman, 3 days after 
cardiac arrest. The patient did not show any brainstem reflexes but had bilateral N20; she 
subsequently died. Bipolar longitudinal montage, 30mm/sec, 10 µV/mm, HFF 70 Hz, LFF 1.0 
Hz. 
2: Background reactivity to auditory stimuli (“clap”) in a 57 year-old man during therapeutic 
hypothermia, 20 hours after cardiac arrest. Upon return to normothermia, he had preserved 
brainstem reflexes and somatosensory evoked potentials, and subsequently awoke. Reduced 
bipolar longitudinal montage, 20mm/sec, 10 µV/mm, HFF 70 Hz, LFF 0.5 Hz. 
3: A. Example of normal, early-latency somatosensory evoked potentials, showing, from bottom 
to top, a plexus (Erb), cervical (N13), and a cortical response (N20, arrow) in a 33 year-old man 
who later awoke. B. Example of absence of the N20 (arrow) despite presence of a plexus and 
cervical response in a 16 year-old girl (who did not survive). 
4: DWI weighted brain MRI of a 60 year-old patient 7 days after a cardiac arrest of respiratory 
origin. Hyper-intensities reflecting reduced water diffusion are mostly seen in posterior cortical 
regions and hippocampi (white arrows).  
5: Stepwise multimodal algorithm for outcome prognostication in comatose adults after cardiac 
arrest. Step 1 includes mandatory investigations, while Step 2 and 3 include confirmatory, 
optional tests. *EEG may be intermittent or continuous. For details, please see text. 
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